Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 244 clinical trials
featured
Type 2 Diabetes - patients after an Acute Coronary Syndrome

Type 2 Diabetes - patients after an Acute Coronary Syndrome

  • 4 views
  • 08 Nov, 2020
  • 1 location
featured
ODYSSEY OUTCOME STUDY - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Have Recently Experienced an Acute Coronary Syndrome

  • 94 views
  • 08 Nov, 2020
  • 1 location
featured
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.

TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.

  • 144 views
  • 08 Nov, 2020
  • 1 location
China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome

In summary, the CHILLAS study will be the first multicenter study performed in a Chinese population using a patient-level analysis to compare the effects and safety of intensive statin therapy with that of moderate statin therapy. Therefore, it will determine whether "lower is better", that is, whether LDL cholesterol lowering …

cardiac event
intravascular ultrasound
LDL Cholesterol
atorvastatin
low density lipoprotein
  • 0 views
  • 07 Nov, 2020
  • 1 location
Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

Cardiogenic shock (CGS) affects up to 10% of patients suffering acute coronary syndrome. It has a 30 day mortality of 45-50%. No pharmacological nor intervention/device trials have had any

  • 0 views
  • 27 Jan, 2021
  • 47 locations
Telemedicine Follow-up for Post-ACS Patients

The aim is to compare the safety of using telemedicine and office visit follow-up in post-acute coronary syndrome patients

  • 0 views
  • 24 Jan, 2021
  • 1 location
Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque

The purpose of this study is to determine whether intensive lipid lowering and Omega-3 fatty acid are effective in the treatment of coronary atherosclerotic plaque.

stenosis
coronary artery stenosis
  • 2 views
  • 07 Nov, 2020
  • 1 location
A Study of Low Dose vs Standard Ticagrelor on Platelet Function After Intervention for Acute Coronary Syndrome in Senior Patients

75 years old)acute coronary syndrome patients . Totally 40 senior ACS patients will be divided into 2 groups randomly one month after PCI . Group 1 will be treated with ticagrelor 90mg and aspirin

  • 0 views
  • 26 Jan, 2021
  • 1 location
Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy

strategy with prasugrel prior to, during and after stent implantation in 75 patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS). Study design: Single arm pilot study with a

  • 0 views
  • 28 Feb, 2021
  • 1 location
A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients

In this study, the investigates try to confirm the hypothesis that low dose ticagrelor(60mg) had similar anti-platelets function compared with the standard dose ticagrelor in acute coronary

  • 0 views
  • 28 Jan, 2021
  • 1 location